MoneyWorks4Me

Marksans Pharma - Quaterly Results

13 Aug 2022 Evaluate
The Revenue for the quarter ended  June 2022 of Rs. 1591.52 millions grew by 8.10 % from Rs. 1472.21 millions.A big decline of -33.56% was reported for the quarter ended June 2022 to Rs. 192.06  millions from Rs. 289.06 millions of corresponding previous quarter.Operating profit for the quarter ended June 2022 decreased to 310.39 millions as compared to 390.37 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 1591.52 1472.21 8.10 1591.52 1472.21 8.10 6582.89 5995.48 9.80
Other Income 194.32 139.40 39.40 194.32 139.40 39.40 422.51 311.56 35.61
PBIDT 310.39 390.37 -20.49 310.39 390.37 -20.49 1559.66 1448.68 7.66
Interest 8.17 6.30 29.68 8.17 6.30 29.68 37.95 53.45 -29.00
PBDT 302.22 384.07 -21.31 302.22 384.07 -21.31 1521.71 1395.23 9.07
Depreciation 45.18 42.29 6.83 45.18 42.29 6.83 176.63 151.93 16.26
PBT 257.04 341.78 -24.79 257.04 341.78 -24.79 1345.08 1243.30 8.19
TAX 64.98 52.72 23.25 64.98 52.72 23.25 305.20 259.49 17.62
Deferred Tax -0.94 -3.52 -73.30 -0.94 -3.52 -73.30 5.04 -22.39 -122.51
PAT 192.06 289.06 -33.56 192.06 289.06 -33.56 1039.88 983.81 5.70
Equity 409.31 409.31 0.00 409.31 409.31 0.00 409.31 409.31 0.00
PBIDTM(%) 19.50 26.52 -26.45 19.50 26.52 -26.45 23.69 24.16 -1.95
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..